Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786093
Dates
24 jul 2016 - 29 jul 2016
Lieu
Big Sky, Montana, États-Unis
Résumé
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Contact
FASEB SRC Staff;     Tél.: [3016347010];     Email.: SRC@faseb.org
Sujets apparentés
2.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC): One and a Half Day In-Person Seminar
ID
823681
Dates
02 aou 2016 - 03 aou 2016
Lieu
San Francisco, États-Unis
Résumé
This interactive one and a half day seminar is intended to help companies understand the legal definitions of cosmetics, drugs, dietary supplements and why certain labeling statements for non-drug products may cause the agency to consider them new drugs without FDA approval.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations, FDA GMPS, good manufacturing practices, over the counter
3.
 
Quality Control Laboratory Compliance - cGMPs and GLPs: One and a Half-day In-person Seminar
ID
823768
Dates
04 aou 2016 - 05 aou 2016
Lieu
San Francisco, États-Unis
Résumé
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices, GLP, cGMP
4.
 
7th Annual Global Pharma Summit
ID
803002
Dates
22 aou 2016 - 24 aou 2016
Lieu
New Orleans, États-Unis
Résumé
Pharma-2016 is a global conclave to discuss and learn about the sessions viz., Pharmaceutical Preformulation, Novel Drug Delivery Systems, Pharma Nanotechnology, Clinical Pharmacy, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmacy Practice, Medicinal Chemistry, Industrial Pharmacy, Regulatory Authorities, Bio and Chemo informatics, Market analysis and Business Opportunity.
5.
 
Drug Discovery & Therapy World Congress 2016 (4th in the Series)
ID
797112
Dates
22 aou 2016 - 25 aou 2016
Lieu
Boston, MA, États-Unis
Résumé
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
Contact
Hasina Habib;     Tél.: [+1-857-2398855];     Email.: hasinahabib@eurekaconference.com
Sujets
Academic CRO/Industrial collaborations in drug discovery Anti-Infectives Bioactive Lipids Biologics Clinical Trials and Regulatory Affairs Cancer Targeted Drug Delivery Cardiovascular Drug Discovery & Therapy Chemistry Combinatorial Chemistry CNS Drug Discovery & Therapy Diabetes and Obesity Drug Discovery & Therapy Drug Delivery & Targeting Drug Discovery in Preclinical Research Drug Metabolism Enabling Technologies Genomics Green Techniques for Medicinal Chemistry High-throughput Screening & Laboratory automation Hot Topics in Drug Targets Hot Topics in HIV Research Hot Topics in Medicinal Chemistry Hot Topics in Natural Products Inflammation and Immunology Innovative Drug Discovery and Nanotechnology In-silico Drug Design and in-silico screening Medical Imaging Nutraceutical Drug Discovery & Therapy Pharmaceutical Biotechnology Pharmaceutical Research & Development Pharmacogenomics Process Chemistry and Drug Manufacturing Protein and Peptide Sciences Proteomics & Bioinformatics Pulmonary Drug Discovery & Therapy Recent Advances in Patient Treatment and Care Recent Advances in Spectroscopy Regenerative Medicine Stereoselective Synthesis of Bioactive Compounds Structural Biology Systems Biology in Drug Design Traditional Chinese Medicine Translational Medicine Women’s Health Drug Discovery & Therapy
6.
 
11th Drug Design & Medicinal Chemistry Conference
ID
806716
Dates
12 sep 2016 - 13 sep 2016
Lieu
Boston, États-Unis
Résumé
We invite you to attend the 11th Drug Design & Medicinal Chemistry Conference, which will take place September 12-13, 2016 in Boston, MA. This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Drug Design, Medicinal Chemistry
7.
 
2016 Pharma CI USA Conference & Exhibition
ID
807126
Dates
13 sep 2016 - 14 sep 2016
Lieu
Parsippany, NJ, États-Unis
Résumé
The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The 2016 Pharma CI USA Conference & Exhibition (Sept. 13-14, 2016, Parsippany, NJ) is the industry's gold standard for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Contact
Ross Frasier;     Email.: ross@pharmaciconference.com
Sujets
pharma, pharmaceutical, biopharma, competitive intelligence, business intelligence
8.
 
Precision: Lung Cancer World Summit 2016
ID
823572
Dates
13 sep 2016 - 14 sep 2016
Lieu
Boston, États-Unis
Résumé
The summit will cover the latest updates from the pipelines of small and large drug developers, and feature discussions around the latest trends in precision medicine through case studies from early discovery to development.
Contact
Grace Hamilton;     Tél.: [+1 617.500.5172];     Email.: grace@neo-synth.com
Sujets
Antibody Drug Conjugates, Immuno-Oncology, Biomarkers / Companion Diagnostics
Sujets apparentés
9.
 
BPA — BioPharm America™ 2016—9th Annual International Partnering Conference
ID
795760
Dates
13 sep 2016 - 15 sep 2016
Lieu
Boston, États-Unis
Résumé
Beginning its ninth year as an industry event, BioPharm America™ creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
Sujets
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
10.
 
BEU — BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
820005
Dates
13 sep 2016 - 15 sep 2016
Lieu
Boston, États-Unis
Résumé
The 22nd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Contact
Camille Del Carmen;     Tél.: [+1 760 930 0500];     Email.: cdelcarmen@ebdgroup.com
Sujets
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Sujets apparentés
11.
 
4th GPCR in Drug Discovery Conference
ID
812586
Dates
14 sep 2016 - 15 sep 2016
Lieu
Boston, États-Unis
Résumé
We invite you to attend the 4th GPCR in Drug Discovery Conference, which will take place September 14-15, 2016 in Boston, MA. G protein-coupled receptors are the largest family of protein receptors and account for one of the largest classes for drug targets currently in the market. Continued breakthrough and insights into the structural biology of GPCRs have opened up greater potential of this target class to impact drug discovery and renewed interest in this field.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets apparentés
12.
 
DOT — 14th Annual Discovery on Target
ID
806837
Dates
19 sep 2016 - 22 sep 2016
Lieu
Boston, MA, États-Unis
Résumé
Cambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
Contact
Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets
drug discovery, drug development, pharma, diseases, genomics, cancer
Sujets apparentés
13.
 
EYE — 4th Annual Targeting Ocular Disorders
ID
806858
Dates
20 sep 2016 - 21 sep 2016
Lieu
Boston, MA, États-Unis
Résumé
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Contact
Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets
ophthalmology, retinal diseases, gene therapy, ocular disorders, drug delivery, stem cells
Sujets apparentés
14.
 
DDS USA 2016 — 3rd Annual Drug Discovery USA Congress 2016
ID
821708
Dates
03 oct 2016 - 04 oct 2016
Lieu
San Diego, États-Unis
Résumé
Oxford Global Conferences are proud to present the 3rd Annual Drug Discovery USA Congress, taking place on 3-4 October 2016 in San Diego, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.
Contact
Guillaume Alonso;     Tél.: [1865248455];     Email.: g.alonso@oxfordglobal.co.uk
Sujets
Drug Discovery, medicinal chemistry, R&D, peptide drug discovery, strategies for target selection, genomic technologies, discovery research, novel stem cell assays, phenotypic screening strategies, primary cells, disease models, supporting innovation with informatics tools, new data analysis, integration platforms, ideas for efficient data exchange, gene editing.
15.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
819576
Dates
06 oct 2016 - 07 oct 2016
Lieu
Philadelphia, États-Unis
Résumé
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
16.
 
World ADC — World ADC San Diego
ID
803030
Dates
10 oct 2016 - 13 oct 2016
Lieu
San Diego, États-Unis
Résumé
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Contact
Jenny Barlow;     Tél.: [+1 212 537 5898];     Email.: info@hansonwade.com
Sujets
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
17.
 
2nd Antibody Drug Conjugates Conference
ID
820042
Dates
24 oct 2016 - 25 oct 2016
Lieu
Boston, États-Unis
Résumé
We invite you to attend the 2nd Antibody Drug Conjugates Conference, which will take place October 24-25, 2016 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
18.
 
4th Protein Expression, Purification & Characterization Conference
ID
825854
Dates
24 oct 2016 - 25 oct 2016
Lieu
Boston, États-Unis
Résumé
GTCbio is proud to present the 4th Protein Expression, Purification & Characterization Conference to be held on October 24-26, 2016 in Boston, MA. This meeting covers important topics including discussions on the expression of difficult proteins, new methods of purification, extended characterization of production cell lines, expression of difficult proteins, and new efficent analytical tools.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Protein Expression, Purification & Characterization
19.
 
4th Antibody & Protein Therapeutics Conference
ID
820098
Dates
25 oct 2016 - 26 oct 2016
Lieu
Boston, États-Unis
Résumé
We welcome you to the 4th Antibody & Protein Therapeutics Conference, which will be held October 25-26, 2016 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.
20.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811152
Dates
26 oct 2016 - 28 oct 2016
Lieu
Baltimore, MD, États-Unis
Résumé
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Immunogenicity, Clinical Relevance, Bioassays, Biologics
21.
 
BAC — 3rd Annual Re-Entering Antibacterial Discovery and Development Summit
ID
825108
Dates
07 dec 2016 - 09 dec 2016
Lieu
Boston, États-Unis
Résumé
By holding the Re-Entering Antibacterial Discovery and Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to overcome the crisis of multidrug resistance, to revive the antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange among all stakeholders participating in discovery and development of new antibacterial agents. It includes several events listed below.
Contact
Pete DeOlympio;     Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Compound validation, Preclinical development, Clinical phases, Regulatory concerns and pathways, Partnership seeking
22.
 
IMVACS — 11th Annual Immunization & Vaccine Summit
ID
825050
Dates
07 dec 2016 - 09 dec 2016
Lieu
Boston, États-Unis
Résumé
Globally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
DNA- and RNA- Based Vaccines, Advances in Vaccine Technologies, Vaccine Adjuvants
Sujets apparentés
23.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811349
Dates
20 fév 2017 - 22 fév 2017
Lieu
Baltimore, États-Unis
Résumé
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Tél.: [1-302-231-6959];     Email.: Vaccines@madrige.com
Sujets
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Sujets apparentés
24.
 
Frontiers in Cancer Immunotherapy
ID
824403
Dates
27 fév 2017 - 28 fév 2017
Lieu
New York, NY, États-Unis
Résumé
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Sujets
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
25.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825399
Dates
05 mar 2017 - 09 mar 2017
Lieu
Breckenridge, Colorado, États-Unis
Résumé
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
26.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825268
Dates
19 mar 2017 - 22 mar 2017
Lieu
Tahoe City, California, États-Unis
Résumé
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Sujets apparentés
27.
 
Keystone Symposia - HIV Vaccines
ID
825192
Dates
26 mar 2017 - 30 mar 2017
Lieu
Steamboat Springs, Colorado, États-Unis
Résumé
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Sujets apparentés
28.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825386
Dates
01 mai 2017 - 04 mai 2017
Lieu
Estes Park, Colorado, États-Unis
Résumé
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Sujets apparentés

États-Unis: liste de tous les évènements/conférences.

5th annual Cancer Vaccines conference
7th annual Biosimilars Europe conference
Superbugs & Superdrugs USA Conference & Exhibition

Bon à savoir...

Vous pouvez insérer un encadré afin de diffuser vos évènements et services dans cet espace.

Dernière mise à jour: 21 Juillet 2016